Medical Center for Human Reproduction, Beijing Chaoyang Hospital, Capital Medical University, #8 Worker's Stadium South Road, Chaoyang District, Beijing, China.
Medical Center for Human Reproduction, Beijing Chaoyang Hospital, Capital Medical University, #8 Worker's Stadium South Road, Chaoyang District, Beijing, China.
Theriogenology. 2020 Jan 1;141:142-145. doi: 10.1016/j.theriogenology.2019.09.008. Epub 2019 Sep 6.
The safety of assisted reproductive technology (ART) is of frequent concern. Unfortunately, animal models for studying the safety of intracytoplasmic sperm injection (ICSI) have limitations in mimicking human ICSI manipulations. As reported herein, we invented a modified holding pipette for mouse oocyte injection that resulted in the delivery of live pups. A modified holding pipette was prepared for mouse oocyte injection and was compared with the conventional pipette for human use and a trumpet-shaped pipette. After ICSI, the oocytes were cultured to cleavage embryos until fallopian transfer. The use of the trumpet-shaped holding pipette and the new modified holding pipette for mouse oocyte injection achieved comparable and satisfactory oocyte survival rates (83.44% and 85.71%, respectively) and embryo cleavage rates (41.98% and 42.42%, respectively), which were significantly higher than those obtained with the human egg-holding pipette (oocyte survival rate: 65.85%; embryo cleavage rate: 27.78%). After 13 embryos were transferred using each type of pipette, three live pups were produced with the new modified holding pipette, one was produced with the holding pipette for human use, and none were produced with the trumpet-shaped holding pipette. The modified holding pipette for oocyte injection is effective and very easy to prepare. Moreover, using this new method, we produced live pups, which will contribute to a useful animal model for safety studies of ICSI in the future.
辅助生殖技术(ART)的安全性备受关注。不幸的是,用于研究胞浆内单精子注射(ICSI)安全性的动物模型在模拟人类 ICSI 操作方面存在局限性。本文报道,我们发明了一种改良的持卵管,用于小鼠卵母细胞注射,可成功产下活幼崽。制备了改良的持卵管用于小鼠卵母细胞注射,并与传统的人类用玻璃吸管和喇叭形玻璃吸管进行了比较。ICSI 后,将卵母细胞培养至卵裂胚胎,然后进行输卵管转移。使用喇叭形持卵管和新型改良的持卵管进行小鼠卵母细胞注射,可获得相当且令人满意的卵母细胞存活率(分别为 83.44%和 85.71%)和胚胎卵裂率(分别为 41.98%和 42.42%),明显高于人类卵持吸管(卵母细胞存活率:65.85%;胚胎卵裂率:27.78%)。使用每种玻璃吸管转移 13 个胚胎后,使用新型改良持卵管产生了 3 只活幼崽,使用人类用玻璃吸管产生了 1 只,而使用喇叭形玻璃吸管未产生活幼崽。用于卵母细胞注射的改良持卵管是有效的,且非常容易制备。此外,使用这种新方法,我们成功产生了活幼崽,这将有助于未来建立用于 ICSI 安全性研究的有用动物模型。